SCHEMBL4365029

SCHEMBL4365029

OCC#Cc1cccc(N=C(NO)c2nonc2[AsH2])c1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 20/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.43
TDO2 P48775 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2518043 0.87 IDO1 (0.64) IDO1LMNAMAPTTDO2
SCHEMBL4365025 0.78 EGFR (0.36)
SCHEMBL4365027 0.78 EGFR (0.36)
SCHEMBL6046566 0.74 IDO1 (0.64) IDO1LMNAMAPTTDO2
SCHEMBL2515558 0.72 IDO1 (0.70) IDO1LMNAMAPTTDO2
SCHEMBL2520953 0.70 IDO1 (0.70) IDO1LMNAMAPTTDO2
SCHEMBL4980796 0.70 IDO1 (0.57) IDO1LMNAMAPT
SCHEMBL4540245 0.68 IDO1 (0.54) IDO1LMNATDO2
SCHEMBL4369904 0.67 IDO1 (0.71) IDO1LMNAMAPTTDO2
SCHEMBL4368299 0.67 IDO1 (0.66) IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879573-A4 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORP (US) 2009-07-08 EP claimed
EP-1879573-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME Incyte Corporation (US) 2008-01-23 EP claimed
WO-2006122150-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2006-11-16 WO claimed